申请人:Ma Zhenkun
公开号:US20050277633A1
公开(公告)日:2005-12-15
Compounds of the current invention relate to rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms. More specifically, compounds of the current invention relate to a series of novel spiro rifamycin derivatives which have demonstrated potent antimicrobial activity.
当前发明的化合物涉及具有抗微生物活性的利福霉素衍生物,包括对耐药微生物的活性。更具体地说,当前发明的化合物涉及一系列表现出强效抗微生物活性的新型螺环利福霉素衍生物。